Authors' reply to Olfson and Schoenbaum, Nardo, Bartlett, Moore, Case, Gøtzsche, and Barber and colleagues

BMJ. 2014 Oct 9:349:g5722. doi: 10.1136/bmj.g5722.

Authors

Christine Y Lu¹, Gregory Simon², Stephen B Soumerai³

Affiliations

¹ Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA christine_lu@harvardpilgrim.org.
² Group Health Research Institute, Seattle, WA, USA.
³ Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.

PMID: 25301799
DOI: 10.1136/bmj.g5722

No abstract available

Publication types

Letter
Comment

MeSH terms

Antidepressive Agents / adverse effects*
Drug Prescriptions / statistics & numerical data*
Female
Humans
Male
Mass Media*
Product Surveillance, Postmarketing*
Suicide*
United States Food and Drug Administration*

Substances

Antidepressive Agents